TrialThe Journal of infectious diseases2012

CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck.

Ziyaad Valley-Omar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.